{"id":"NCT02161146","sponsor":"Allergan","briefTitle":"AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06-04","primaryCompletion":"2014-12-20","completion":"2014-12-20","firstPosted":"2014-06-11","resultsPosted":"2016-03-07","lastUpdate":"2019-04-17"},"enrollment":240,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Conjunctivitis, Allergic"],"interventions":[{"type":"DRUG","name":"AGN-229666","otherNames":[]},{"type":"DRUG","name":"Vehicle to AGN-229666","otherNames":[]},{"type":"DRUG","name":"Olopatadine","otherNames":["PatanolÂ®"]}],"arms":[{"label":"AGN-229666","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"},{"label":"Olopatadine","type":"ACTIVE_COMPARATOR"},{"label":"AGN-229666/Olopatadine","type":"OTHER"},{"label":"AGN-229666/Vehicle","type":"OTHER"}],"summary":"This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.","primaryOutcome":{"measure":"Ocular Itching Score","timeFrame":"Days 1 and 15","effectByArm":[{"arm":"AGN-229666","deltaMin":0.33,"sd":0.523},{"arm":"Vehicle","deltaMin":1.48,"sd":0.904},{"arm":"Olopatadine","deltaMin":0.29,"sd":0.411}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":2},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["29543548"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":47},"commonTop":["Oropharyngeal discomfort","Oropharyngeal pain","Nasopharyngitis","Rhinorrhoea"]}}